Research theme for competitive and other funds (5):
2022 - 2025 茶カテキンコーティング金ナノ粒子を用いた新規放射線治療増感剤の開発
2021 - 2024 がん早期診断における涙液エクソソームの有用性の検討
2017 - 2020 Studies on characteristics and prognosis of breast cancer with late recurrence
2017 - 2020 Prediction of treatment effect using radiomics analysis with MRI for individual treatment of breast cancer
2014 - 2017 Study on clinicopathological characteristics and predictive factors for breast cancer with late recurrence
Papers (21):
Sachiko Inubushi, Tomonari Kunihisa, Marina Kuniyasu, Shotaro Inoue, Mayuko Yamamoto, Yuji Yamashita, Mayuko Miki, Sachiko Mizumoto, Motoi Baba, Robert M Hoffman, et al. Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden. Cancer genomics & proteomics. 2024. 21. 6. 580-584
Kenichi Watanabe, Kanako Hagio, Motoi Baba, Mayuko Ikarashi, Masako Sato, Nobumoto Tomioka, Masato Takahashi. Anti-HER2 therapy for HER2-positive metastatic breast cancer: regimens and treatment outcomes. ANNALS OF ONCOLOGY. 2015. 26. 143-143
Education (2):
- 2015 北海道大学大学院 医学部 医学科 博士課程
1997 - 2003 Akita University School of Medicine School of Medicine
Professional career (1):
博士 (北海道大学医学部)
Awards (1):
2017 - 日本外科学会 第23回(平成28年度)研究奨励賞 Strong cytoplasmic expression of NF-κB/p65 correlates with a good prognosis in patients with triple-negative breast cancer
Association Membership(s) (5):
日本癌学会
, Japanese Society of Medical Oncology
, The Japanese Breast Cancer Society
, JAPAN SOCIETY OF CLINICAL ONCOLOGY
, JAPAN SURGICAL SOCIETY